tldrdaily.news logo

FDA Approves Groundbreaking Opioid Addiction Test and Safety Labeling Changes

1 min read
Source: Reuters
FDA Approves Groundbreaking Opioid Addiction Test and Safety Labeling Changes
Photo: Reuters
TL;DR Summary

The US FDA has approved the first test, called AvertD, to assess the risk of opioid use addiction in certain individuals. Developed by SOLVD Health, the test is intended to be used before the first use of oral opioid painkillers in patients who are being considered for a short-term prescription for acute pain. AvertD is a genetic laboratory test that analyzes DNA samples to determine if there are genetic variants associated with an elevated risk of developing opioid use disorder. It is not intended for use in patients being treated for chronic pain.

Topics:business#avertd#fda#genetic-test#health#opioid-addiction#solvd-health
Share this article
  1. US FDA approves first test to identify opioid use addiction risk  Reuters
  2. FDA approves safety labeling changes for opioid pain medicines  FDA.gov
  3. FDA approves first test to help screen for risk of opioid use disorder  CNN
  4. Rheumatoid Arthritis Quiz: RA Treatment and the Risk of Serious Cardiovascular Events  MD Magazine
  5. FDA Roundup: December 15, 2023  PR Newswire

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

1 min

vs 2 min read

Condensed

66%

271 → 93 words

Want the full story? Read the original article

Read on Reuters